C000218694 Performance — Thrivent Mid Cap Growth Portfolio, Class A
Data updated: 2026-08-26
C000218694 returned +12.77% year to date and +13.59% over one year to Jun 2026. Annualised returns are +9.37% over 3 years and +2.08% over 5 years. The fund trailed its US Mid-Cap Growth category average: $100 invested three years ago grew to $131, against $152 for the category, and to $114 over one year, against $118. Volatility over the past three years was 17.38% a year. In the 12 months to Jun 2026 the fund lost a net $8.6M, and assets reached $92.49M.
C000218694 Growth of $100
What $100 invested in Thrivent Mid Cap Growth Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Growth category average over the same months.
| Period | C000218694 | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $114 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $131 | $152 |
| 5 years (Jul 2021 – Jun 2026) | $111 | $129 |
| Since data start (Apr 2020 – Jun 2026) | $180 | $238 |
C000218694 Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +12.77% |
| 1 year | +13.59% |
| 3 years (annualised) | +9.37% |
| 5 years (annualised) | +2.08% |
C000218694 Annual Returns
Calendar-year total returns of Thrivent Mid Cap Growth Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +12.77% |
| 2025 | +2.50% |
| 2024 | +10.12% |
| 2023 | +17.12% |
| 2022 | −28.52% |
| 2021 | +11.80% |
| 2020 (Apr–Dec) | +51.20% |
C000218694 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0% | +1.0% | −6.9% | +10.3% | +4.5% | +4.1% | — | — | — | — | — | — |
| 2025 | +5.5% | −5.6% | −8.3% | +0.2% | +6.1% | +4.8% | +1.9% | +1.1% | +1.9% | −1.3% | −0.9% | −2.0% |
| 2024 | −0.7% | +7.7% | +2.3% | −7.4% | +1.7% | −0.4% | +3.4% | +0.9% | +1.9% | −0.4% | +8.4% | −6.6% |
| 2023 | +8.9% | −1.5% | −0.2% | −1.3% | −0.8% | +8.8% | +3.1% | −3.7% | −5.7% | −6.9% | +9.4% | +7.9% |
| 2022 | −14.7% | −0.4% | −0.1% | −10.2% | −3.5% | −7.2% | +12.0% | −1.7% | −9.0% | +6.0% | +4.3% | −5.5% |
| 2021 | −0.8% | +4.6% | −3.5% | +6.1% | −3.5% | +4.8% | +2.9% | +3.1% | −3.7% | +6.0% | −4.6% | +0.7% |
| 2020 | — | — | — | 0.0% | +12.0% | +1.8% | +6.4% | +4.9% | −0.9% | −1.1% | +14.2% | +6.3% |
C000218694 Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 17.38%
- 3-year Sharpe ratio: 0.28 (vs 4.5% risk-free rate)
- Best month: +10.31% (Apr 2026)
- Worst month: −8.35% (Mar 2025)
C000218694 Fund Flows
Monthly money in and out of Thrivent Mid Cap Growth Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$8.6M
- 12-month gross sales (incl. reinvestments): $6.0M
- Sales ÷ redemptions: 0.41×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $402K | $1.6M | −$1.2M |
| May 2026 | $361K | $1.2M | −$832K |
| Apr 2026 | $380K | $1.2M | −$803K |
| Mar 2026 | $681K | $753K | −$72K |
| Feb 2026 | $862K | $1.9M | −$1.0M |
| Jan 2026 | $397K | $1.6M | −$1.2M |
| Dec 2025 | $783K | $765K | $19K |
| Nov 2025 | $476K | $1.4M | −$941K |
| Oct 2025 | $755K | $808K | −$53K |
| Sep 2025 | $399K | $1.2M | −$753K |
| Aug 2025 | $355K | $1.5M | −$1.1M |
| Jul 2025 | $184K | $853K | −$669K |
C000218694 Assets Under Management
Net assets of Thrivent Mid Cap Growth Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $92.49M |
| 2026-03-31 | $79.36M |
| 2025-12-31 | $86.88M |
| 2025-09-30 | $91.58M |
| 2025-06-30 | $89.79M |
| 2025-03-31 | $81.63M |
| 2024-12-31 | $90.24M |
| 2024-09-30 | $90.46M |
| 2024-06-28 | $85.77M |
| 2024-03-28 | $88.71M |
| 2023-12-29 | $77.70M |
| 2023-09-29 | $70.45M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.